Replimune Group Inc (REPL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REPL | LXRX | RVNC | ||
| Company | Replimune Group Inc | Lexicon Pharmaceutcl | Revance Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.54 | 1.7300 | 3.91 | ||
| High | 6.66 | 1.7500 | 3.99 | ||
| Low | 6.37 | 1.6500 | 3.66 | ||
| Last | 6.57 | 1.6900 | 3.75 | ||
| Change | +0.09 | +0.0400 | -0.05 | ||
| % Change | +1.39% | +2.42% | -1.32% | ||
| Volume | 170,648 | 3,304,648 | 776,009 | ||
| 20-Day Average Volume | 758,092 | 2,968,525 | 1,831,049 | ||
| Previous Close | 6.48 | 1.6500 | 3.80 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.78 | 1.7587 | 3.90 | ||
| 20-Day Raw Stochastic | 39.78% | 29.06% | 29.77% | ||
| 20-Day Relative Strength | 41.53% | 42.48% | 39.19% | ||
| Weighted Alpha | -54.51 | -53.68 | -85.21 | ||
| Today's Opinion | 100% Sell | 8% Buy | 100% Sell | ||
| Previous Opinion | 100% Sell | 24% Sell | 100% Sell | ||
| Last Month's Opinion | 88% Sell | 40% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.32% since 04/25/24 | +9.09% since 04/25/24 | +13.22% since 04/25/24 | ||
| Low | 6.06 on 04/26/24 | 1.4800 on 04/30/24 | 3.21 on 04/26/24 | ||
| High | 6.78 on 04/29/24 | 1.7700 on 05/01/24 | 4.06 on 05/01/24 | ||
| 1-Month | |||||
| %Chg | -7.43% since 04/02/24 | -23.98% since 04/02/24 | -17.41% since 04/02/24 | ||
| Low | 5.86 on 04/25/24 | 1.4800 on 04/30/24 | 3.21 on 04/26/24 | ||
| High | 7.72 on 04/05/24 | 2.2392 on 04/03/24 | 4.94 on 04/09/24 | ||
| 3-Month | |||||
| %Chg | -10.08% since 02/02/24 | -21.13% since 02/02/24 | -30.63% since 02/02/24 | ||
| Low | 5.86 on 04/25/24 | 1.4800 on 04/30/24 | 3.21 on 04/26/24 | ||
| High | 9.20 on 03/11/24 | 3.7300 on 02/16/24 | 7.56 on 03/01/24 | ||
| 6-Month | |||||
| %Chg | -51.61% since 11/02/23 | +20.00% since 11/02/23 | -55.86% since 11/02/23 | ||
| Low | 5.86 on 04/25/24 | 0.9200 on 11/10/23 | 3.21 on 04/26/24 | ||
| High | 14.72 on 11/06/23 | 3.7300 on 02/16/24 | 9.74 on 01/02/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 397,794 | 406,291 | 395,500 | ||
| Shares Outstanding, K | 61,388 | 246,237 | 104,216 | ||
| Annual Sales | 0 | 1,200,000 | 234,040,000 | ||
| Annual Net Income | -174,280,000 | -177,120,000 | -323,990,000 | ||
| Last Quarter Sales | 0 | 700,000 | 69,800,000 | ||
| Last Quarter Net Income | -51,120,000 | -49,760,000 | -55,700,000 | ||
| 60-Month Beta | 1.25 | 1.38 | 1.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.77 on 02/08/24 | -0.20 on 03/11/24 | -0.62 on 02/28/24 | ||
| Latest Earnings Date | 05/16/24 | 05/02/24 | 05/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||